1. Safety and efficacy of teneligliptin in patients with type 2 diabetes mellitus and impaired renal function: interim report from post-marketing surveillance;Haneda;Diabetes Therapy,2018
2. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes research and clinical practice;Saeedi,2019
3. QT/QTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the “thorough QT/QTc” study (Q-SET study);Erande;Diabetes, Metab Syndrome Obes Targets Ther,2019
4. Prospective observational study on the analysis of utilisation pattern, safety and effectiveness of teneligliptin in type 2 diabetic patients with cardiovascular disease;George;World J Pharmaceut Res,2018
5. Cardiovascular safety of dipeptidyl peptidase-4 inhibitors: recent evidence on heart failure;Kankanala;Am J Transl Res,2016